Oana Georgiana Oprea
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Oana Georgiana Oprea has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Alin Ciobica
“Ioan Haulica” Institute, Apollonia University, 700511 Iasi, Romania
3 shared publications - Mircea Nicusor Nicoara
Doctoral School of Geosciences, Faculty of Geography and Geology, “Alexandru Ioan Cuza” University of Iasi, 700505 Iasi, Romania
3 shared publications - Gabriel Plavan
Department of Biology, Faculty of Biology, Alexandru Ioan Cuza University of Iasi, Iasi, Romania
2 shared publications - Ioana-Miruna Balmus
Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iași, Romania
2 shared publications - Antoneta Dacia Petroaie
“Grigore T. Popa” University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania
1 shared publication - Bogdan Novac
Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania
1 shared publication
Latest Publications
- Open Access
- 16 September 2026
- Published by Asociatia EduSoft in BRAIN. BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE
- Vol. 17 (3) , 416-427
Preliminary Data Regarding the Neurobehavioural Modulatory Effect of Acmella Oleracea L. Extract in an Zebrafish Model of Autism Spectrum Disorder
Plant-derived extracts, such as those obtained from Acmella oleracea (L.) R.K. Jansen (AO), have drawn increasing interest due to possible neuroprotective properties. Several reports of neuroprotective potential were attributed to the main bioactive component of AO extract, spilanthol. Due to its capacity of spilanthol to cross the blood-brain barrier and to modulate serotonergic and GABAergic systems, AO extract may represent a promising experimental candidate for investigating effects on autism spectrum disorder (ASD) relevant behavioural symptoms, such as anxiety and aggression. The most common drug to model core symptoms of autism spectrum disorder (ASD) in zebrafish is the antiepileptic valproic acid (VPA). The current study aimed to evaluate the behavioural effects of AO extract in zebrafish, as compared to or in combination with VPA, to assess their effects on anxiety-like and aggressive behaviour, as assessed by the novel tank test (NTT) and the mirror-biting test (MBT). Our findings suggest that VPA-treated zebrafish show an increased frequency of aggressive and anxiety-like behaviours, as compared to controls. Similar anxiety-like, but not aggressive, behavioural changes were seen in AO-treated zebrafish. These effects may be connected with the modulation of GABAergic neurotransmission. Moreover, we observed that acute AO extract treatment was not able to modulate aggressive behaviour in VPA-treated or in healthy zebrafish.
- 16 September 2026
- Published by Asociatia EduSoft in BRAIN. BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE
- Vol. 17 (3) , 416-427
Open AccessPreliminary Data Regarding the Neurobehavioural Modulatory Effect of Acmella Oleracea L. Extract in an Zebrafish Model of Autism Spectrum Disorder
Plant-derived extracts, such as those obtained from Acmella oleracea (L.) R.K. Jansen (AO), have drawn increasing interest due to possible neuroprotective properties. Several reports of neuroprotective potential were attributed to the main bioactive component of AO extract, spilanthol. Due to its capacity of spilanthol to cross the blood-brain barrier and to modulate serotonergic and GABAergic systems, AO extract may represent a promising experimental candidate for investigating effects on autism spectrum disorder (ASD) relevant behavioural symptoms, such as anxiety and aggression. The most common drug to model core symptoms of autism spectrum disorder (ASD) in zebrafish is the antiepileptic valproic acid (VPA). The current study aimed to evaluate the behavioural effects of AO extract in zebrafish, as compared to or in combination with VPA, to assess their effects on anxiety-like and aggressive behaviour, as assessed by the novel tank test (NTT) and the mirror-biting test (MBT). Our findings suggest that VPA-treated zebrafish show an increased frequency of aggressive and anxiety-like behaviours, as compared to controls. Similar anxiety-like, but not aggressive, behavioural changes were seen in AO-treated zebrafish. These effects may be connected with the modulation of GABAergic neurotransmission. Moreover, we observed that acute AO extract treatment was not able to modulate aggressive behaviour in VPA-treated or in healthy zebrafish.
- Open Access
- 23 February 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (2) , 343
Preliminary Data Regarding the Potential of Oxytocin to Modulate Aggressive Behaviour in a VPA-Based Animal Model of Autism Spectrum Disorder
Background/Objectives: Aggressive behaviour is commonly associated with neurodevelopmental disorders, such as autism spectrum disorder (ASD), and could be understood as a response to daily stress routines, which negatively impacts patients’ quality of life. Oxytocin (OT), a neuropeptide involved in social bonding and socio-affective regulation, has emerged as a promising candidate to enrich, rather than replace, current pharmacological approaches in managing ASD-associated aggressive behaviour. In this study, we examined the potential of OT to modulate aggressive behaviour frequency in a VPA-based animal model of ASD. Methods: Sixty adult zebrafish (1:1 sex ratio) were divided into six groups (n = 10/group) and received the following treatment for 7 consecutive days: CTR—control (no treatment); VPA (28.8 mg/L valproic acid); OT (33.2 ng/mL oxytocin); RIS (170 μg/L risperidone); VPA + OT (28.8 mg/L valproic acid and 33.2 ng/mL oxytocin); and VPA + RIS (28.8 mg/L valproic acid and 170 μg/L risperidone). The locomotor performance, and socio-affective and aggressive behaviours, were measured in the Novel Tank and Mirror Biting tests at the end of the treatments. Results: We observed that the VPA treatment led to locomotion and socio-affective impairments, as well as aggressive behaviour. Also, we found that OT and RIS had comparable potential to modulate the frequency of aggressive and anxiety-like behaviours. Conclusions: Our preliminary data showed that OT has the potential to modulate the frequency of anxiety-like and aggressive behaviours, similarly to the atypical antipsychotic, RIS, in our VPA zebrafish model. However, further studies are needed to investigate the mechanisms of action and their potential synergistic effects.
- 23 February 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (2) , 343
Open AccessPreliminary Data Regarding the Potential of Oxytocin to Modulate Aggressive Behaviour in a VPA-Based Animal Model of Autism Spectrum Disorder
Background/Objectives: Aggressive behaviour is commonly associated with neurodevelopmental disorders, such as autism spectrum disorder (ASD), and could be understood as a response to daily stress routines, which negatively impacts patients’ quality of life. Oxytocin (OT), a neuropeptide involved in social bonding and socio-affective regulation, has emerged as a promising candidate to enrich, rather than replace, current pharmacological approaches in managing ASD-associated aggressive behaviour. In this study, we examined the potential of OT to modulate aggressive behaviour frequency in a VPA-based animal model of ASD. Methods: Sixty adult zebrafish (1:1 sex ratio) were divided into six groups (n = 10/group) and received the following treatment for 7 consecutive days: CTR—control (no treatment); VPA (28.8 mg/L valproic acid); OT (33.2 ng/mL oxytocin); RIS (170 μg/L risperidone); VPA + OT (28.8 mg/L valproic acid and 33.2 ng/mL oxytocin); and VPA + RIS (28.8 mg/L valproic acid and 170 μg/L risperidone). The locomotor performance, and socio-affective and aggressive behaviours, were measured in the Novel Tank and Mirror Biting tests at the end of the treatments. Results: We observed that the VPA treatment led to locomotion and socio-affective impairments, as well as aggressive behaviour. Also, we found that OT and RIS had comparable potential to modulate the frequency of aggressive and anxiety-like behaviours. Conclusions: Our preliminary data showed that OT has the potential to modulate the frequency of anxiety-like and aggressive behaviours, similarly to the atypical antipsychotic, RIS, in our VPA zebrafish model. However, further studies are needed to investigate the mechanisms of action and their potential synergistic effects.
- Open Access
- 22 February 2024
- Published by MDPI AG in Brain Sciences
- Vol. 14 (3) , 203
Oxytocin Enhances Time-Dependent Responses in the Aggressive Zebrafish (Danio rerio)
Autism spectrum disorder (ASD) has become one of the most well-known disorders encountered since early childhood among people. Nowadays, the main concerns are its high prevalence and the lack of proper therapeutic interventions. In this way, the necessity of using animal models that can mimic some of the spectrum symptoms, besides deepening the mechanisms of occurrence, is undeniable. Oxytocin (OT) is often mentioned and linked to producing social domain improvements. The goal of the present study was to determine if different time exposures to OT can trigger distinct behavioral responses in zebrafish, potentially offering insights into autism therapy. To accomplish this goal, zebrafish were exposed to the same dose of OT (33.2 ng/mL OT) for one week but with different time frames, such as: continuous exposure for seven days, fifteen minutes per day for seven days, and every two days for the same amount of time. The behavior of the fish was recorded using the EthoVision XT 11.5 software, and each trial lasted four minutes. Specific parameters for locomotor activity and aggressive behavior were measured. Overall, zebrafish exposure to OT generated several improvements in locomotor activity and aggressive behavior. Moreover, the differences in the exposure period indicated that time is an important factor, showing that continuous exposure to OT was linked with better performance than exposure to the hormone every two days. At the same time, the most variable results were observed in the case of fish exposed every day to OT. Exposure to OT could lead to certain improvements in zebrafish behavior that can be time-sensitive. Nevertheless, further work is needed in order to investigate the mechanisms of action of OT in an ASD context.
- 22 February 2024
- Published by MDPI AG in Brain Sciences
- Vol. 14 (3) , 203
Open AccessOxytocin Enhances Time-Dependent Responses in the Aggressive Zebrafish (Danio rerio)
Autism spectrum disorder (ASD) has become one of the most well-known disorders encountered since early childhood among people. Nowadays, the main concerns are its high prevalence and the lack of proper therapeutic interventions. In this way, the necessity of using animal models that can mimic some of the spectrum symptoms, besides deepening the mechanisms of occurrence, is undeniable. Oxytocin (OT) is often mentioned and linked to producing social domain improvements. The goal of the present study was to determine if different time exposures to OT can trigger distinct behavioral responses in zebrafish, potentially offering insights into autism therapy. To accomplish this goal, zebrafish were exposed to the same dose of OT (33.2 ng/mL OT) for one week but with different time frames, such as: continuous exposure for seven days, fifteen minutes per day for seven days, and every two days for the same amount of time. The behavior of the fish was recorded using the EthoVision XT 11.5 software, and each trial lasted four minutes. Specific parameters for locomotor activity and aggressive behavior were measured. Overall, zebrafish exposure to OT generated several improvements in locomotor activity and aggressive behavior. Moreover, the differences in the exposure period indicated that time is an important factor, showing that continuous exposure to OT was linked with better performance than exposure to the hormone every two days. At the same time, the most variable results were observed in the case of fish exposed every day to OT. Exposure to OT could lead to certain improvements in zebrafish behavior that can be time-sensitive. Nevertheless, further work is needed in order to investigate the mechanisms of action of OT in an ASD context.